Background: Biliary tract cancers (BTCs) are heterogenous. highly aggressive tumors that harbor a dismal prognosis for which more effective treatments are needed. The role of cancer immunotherapy in BTC remains to be characterized. The tumor microenvironment (TME) of BTC is highly immunosuppressed and combination treatments are needed to promote effective anticancer immunity. https://ashleyshomestores.shop/product-category/queen-platform-base/